Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
21.90
+4.90 (28.82%)
At close: Aug 5, 2026, 4:00 PM EDT
21.11
-0.79 (-3.61%)
After-hours: Aug 5, 2026, 7:46 PM EDT
Attovia Therapeutics Revenue
Attovia Therapeutics had revenue of $1.35M in the twelve months ending March 31, 2026. In the year 2025, Attovia Therapeutics had annual revenue of $1.35M.
Revenue (ttm)
$1.35M
Revenue Growth
n/a
P/S Ratio
698.03
Revenue / Employee
$30,682
Employees
44
Market Cap
942.34M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.35M | - | - |
| Dec 31, 2024 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
ATTO News
- 8 hours ago - Attovia opens at $21.00, IPO priced at $17.00 - TheFly
- 8 hours ago - Attovia indicated to open at $20, IPO priced at $17 - TheFly
- 9 hours ago - Attovia indicated to open at $24, IPO priced at $17 - TheFly
- 23 hours ago - Attovia Therapeutics Announces Pricing of Upsized Initial Public Offering - GlobeNewsWire
- 1 day ago - Goldman Sachs-backed Attovia eyes $731.5 million valuation in upsized US IPO - Reuters
- 21 days ago - Attovia Therapeutics Appoints John W. Smither to Board of Directors - GlobeNewsWire
- 22 days ago - Biopharmaceutical company Attovia Therapeutics files for US IPO - Reuters
- 22 days ago - Attovia Therapeutics - SEC